The Optimal Number of Fiducial Marker for Stereotactic Body Radiotherapy
NCT06342323
·
clinicaltrials.gov ↗
UNKNOWN
Status
57
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer
Liver Cancer
Pancreatic Cancer
Renal Cell Carcinoma
Interventions
RADIATION:
SBRT
Sponsor
Peking University Third Hospital